SETD7 and neoplasm: For example, the human osteosarcoma tumor cell line U2OS and human cervical cancer cell line HeLa were frequently used for establishing SET7/9-overexpressing or SET7/9-silencing models to examine the interaction between SET7/9 and its substrates and the cellular biological effects of altered SET7/9 expression.